GRDN vs PACS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 09, 2026

GRDN

40.9
AI Score
VS
PACS Wins

PACS

61.8
AI Score

Investment Advisor Scores

GRDN

41score
Recommendation
HOLD

PACS

62score
Recommendation
BUY

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric GRDN PACS Winner
Revenue 688.36M 2.85B PACS
Net Income 35.17M 157.06M PACS
Net Margin 5.1% 5.5% PACS
Operating Income 38.32M 229.37M PACS
ROE 13.6% 14.1% PACS
ROA 7.9% 2.8% GRDN
Total Assets 443.58M 5.66B PACS
Cash 89.81M 164.45M PACS
Current Ratio 1.65 0.91 GRDN

Relative Price Performance (Last 90 Days)

GRDN 1M: +13.1% · 3M: +1.3% PACS 1M: -1.6% · 3M: +28.8%

Current Technical Phase

GRDN

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 69

RSI (14): 69.5 · Price: $43.64

PACS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 54

RSI (14): 54.5 · Price: $44.76

Fundamentals Snapshot

Metric GRDN PACS
Market Cap
Forward P/E 30.5 16.5
Trailing P/E 41.7 26.1
Revenue (TTM)
Revenue Growth 0.0% 0.1%
Gross Margin 0.2% 0.2%
Operating Margin 0.0% 0.1%
EPS 1.05 1.72
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, PACS is currently the stronger investment candidate, winning 7 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.